EP 1007026 A4 20020807 - INTEGRIN ANTAGONISTS
Title (en)
INTEGRIN ANTAGONISTS
Title (de)
INTEGRIN-ANTAGONISTEN
Title (fr)
ANTAGONISTES D'INTEGRINE
Publication
Application
Priority
- GB 9702788 A 19970211
- GB 9725996 A 19971209
- US 9800617 W 19980113
- US 3561497 P 19970117
- US 6259497 P 19971020
Abstract (en)
[origin: WO9831359A1] This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as vitronectin receptor antagonists. The vitronectin receptor antagonist compounds of the present invention are alpha v beta 3 antagonists, alpha v beta 5 antagonists or dual alpha v beta 3/ alpha v beta 5 antagonists useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, viral disease, and tumor growth.
IPC 1-7
IPC 8 full level
C07D 235/16 (2006.01); A61K 31/198 (2006.01); A61K 31/4184 (2006.01); A61K 31/4375 (2006.01); A61K 31/44 (2006.01); A61K 31/66 (2006.01); A61K 45/06 (2006.01); A61P 9/10 (2006.01); A61P 19/10 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 213/73 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP)
A61K 31/66 (2013.01); A61P 9/10 (2017.12); A61P 19/10 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07D 471/04 (2013.01)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 9831359A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9831359 A1 19980723; AU 6023198 A 19980807; AU 729869 B2 20010215; CA 2277273 A1 19980723; CA 2277273 C 20080325; EP 1007026 A1 20000614; EP 1007026 A4 20020807; JP 2001509176 A 20010710
DOCDB simple family (application)
US 9800617 W 19980113; AU 6023198 A 19980113; CA 2277273 A 19980113; EP 98903466 A 19980113; JP 53447398 A 19980113